In another study, the same group employed combined vaccination with cancer self-antigens and anti-GITR antibody application for analysis of protection from B16 tumor challenge in C57BL/6 mice and addressed, among others, the effects of GITR triggering on CD8+ T cell responses [78]. Here, TNFRSF18 is linked to cancer.